CliffBio
biologic

Menopur

menotropins

Loss of exclusivityOctober 2016projected — 12-year biologic exclusivity estimate
CompanyFerring Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameMenopur
Active ingredientmenotropins
Strength75IU
Dosage formFor Injection
RouteSubcutaneous
ModalityBiologic
FDA approvalOctober 2004
Marketing statusRx

More from Ferring Pharmaceuticals

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.

Menopur patent cliff — loss of exclusivity October 2016 | CliffBio